|
-综合管理部-
|
||
|
-党建工作部-
|
||
|
科技管理处
|
||
|
-人力资源部-
|
||
|
财务资产处
|
|
-钍基核裂变能全国重点实验室
|
||||
|
-钍基核能物理中心-
|
||||
|
熔盐机械工程技术部
|
||||
|
仪控工程技术部
|
||||
|
熔盐化学工程技术部
|
||||
|
-核能综合利用研究中心-
|
||||
|
特种堆技术研究室
|
||||
|
材料研究部
|
||||
|
钍铀循环化学部
|
||||
|
应用化学技术部
|
||||
|
氚科学与工程技术部
|
||||
|
核与辐射安全技术部
|
||||
|
建安工程技术部
|
||||
|
应用加速器技术部
|
||||
|
反应堆运行技术部
|
||||
|
-项目管理中心-
|
|
-国家制氢装备及安全质量检验检测中心
|
|
-所级公共技术中心
|
|
-辐射安全检测中心
|
|
-核能科学分析测试中心
|
|
-核电站仪表辐照试验室
|
|
-制氢材料与氢能产品检验检测中心
|
|
-信息中心
|
|
-综合保障中心
|
|
-日环科技投资公司
|
|
-武威园区管理办公室
|
|
-武威园区安保办公室
|
报告题目:Three-dimensional microelectrodes as ultrasenstive biomolecular detectors
报 告 人:Dr. Shana Kelley(University of Toronto)
报告时间:2016年9月20日(星期二)下午2:00
报告地点:嘉定园区学术活动中心多功能厅
报告人简介:
Dr. Shana Kelley is a Distinguished Professor of Pharmaceutical Sciences, Chemistry, Biochemistry, and Biomedical Engineering at the University of Toronto. Dr. Kelley received her Ph.D. from the California Institute of Technology and was a NIH postdoctoral fellow at the Scripps Research Institute.
The Kelley research group works in a variety of areas spanning bioanalytical chemistry, chemical biology and nanotechnology. Shana’s group has developed novel electrochemical sensors that enable ultrasensitive nucleic acids detection for clinical diagnostics, and has also investigated a new set of chemical probes that interact with intracellular nucleic acids. The Kelley labs also use nucleic acids as building blocks for complex nanomaterials assembly.
Dr. Kelley’s work has been recognized with a variety of distinctions, including being named one of “Canada’s Top 40 under 40”, a NSERC E.W.R. Steacie Fellow, and the 2011 Steacie Prize. She has also been recognized with the Pittsburgh Conference Achievement Award, an Alfred P. Sloan Research Fellowship, a Camille Dreyfus Teacher-Scholar award, a NSF CAREER Award, a Dreyfus New Faculty Award, and was also named a “Top 100 Innovator” by MIT’s Technology Review. She is a founder of two molecular diagnostics companies, GeneOhm Sciences (acquired by Becton Dickinson in 2005) and Xagenic Inc.